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ABSTRACT 
 
BACKGROUND! Masseter area (MA), a surrogate for sarcopenia, appears to be useful when 
estimating postoperative survival, but there is lack of consensus regarding the potential predictive 
value of sarcopenia in acute ischemic stroke (AIS) patients. We hypothesized that MA and density 
(MD) evaluated from pre-interventional computed tomography angiography (CTA) scans predict 
postinterventional survival in patients undergoing mechanical thrombectomy (MT). 
MATERIALS AND METHODS! 312 patients treated with MT for acute occlusions of the internal 
carotid artery (ICA) or the M1 segment of the middle cerebral artery (M1-MCA) between 2013 and 
2018. Median follow-up was 27.4 months (range 0-70.4). Binary logistic (alive at 3 months, OR<1) 
and Cox regression analyses were used to study the effect of MA and MD averages (MAavg and 
MDavg) on survival.  
RESULTS. In Kaplan-Meier analysis, there was a significant inverse relationship with both MDavg 
and MAavg and mortality (MDavg p<.001, MAavg p=.002). Long-term mortality was 19.6% (n=61) 
and three-month mortality 12.2% (n=38). In multivariable logistic regression analysis at three 
months, per 1-SD increase MDavg (OR 0.61, 95% CI 0.41-0.92, p=.018:) and MAavg (OR 0.57, 95% 
CI 0.35-0.91, p=.019) were the independent predictors associated with lower mortality. In Cox 
regression analysis, MDavg and MAavg were not associated with long-term survival. 
CONCLUSIONS. In acute ischemic stroke patients, MDavg and MAavg are independent predictors 
of three-month survival after MT of the ICA or M1-MCA. A 1-SD increase in MDavg and MAavg 
was associated with a 39-43% decrease in the probability of death during the first three months after 
MT.
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INTRODUCTION 
 
Acute ischemic stroke (AIS) continues to be a significant cause of disability and mortality 
worldwide.[1] Several randomized trials have demonstrated that mechanical thrombectomy (MT) is 
the treatment of choice in patients with acute proximal anterior circulation ischemic stroke.[2–6] The 
number of patients receiving MT is increasing as this treatment is recommended by clinical practice 
guidelines, the time window from symptom onset to treatment has been widened, and the overall 
stroke treatment chain has been enhanced.[7] Optimising patient selection is crucial in order to 
efficiently allocate resources and to continue to improve the overall clinical outcome, especially 
survival, after AIS. 
 
Recognized predictors of survival after a large vessel ischemic stroke include stroke severity, good 
collateral circulation, age, sex, diabetes, atrial fibrillation, renal insufficiency, frailty, and intracranial 
hemorrhage. The Alberta stroke program early computed tomography (CT) score (ASPECTS) has 
also been validated as a risk assessment tool in this cohort.[8–10] Muscle loss, i.e. sarcopenia, is a 
major component of frailty. In elderly patients, masseter muscle area correlates with psoas muscle 
area,[11] which has previously been verified to predict mortality in vascular surgical patients.[12–14] 
Additionally, masseter area measured from CT scans has been used in evaluating sarcopenia in carotid 
endarterectomy[15] and elderly blunt trauma patients[11] as well as after severe traumatic brain 
injury.[16,17] In addition to muscle area, radiodensity has also been ascertained as a marker of 
sarcopenia.[18] Furthermore, masseter muscle tension and chewing ability correlate with physical 
fitness and quality of life in the elderly.[19] Sarcopenia can be reliably diagnosed from CT scans by 
a clinician by measuring muscle area and density from a representative slice.[18,20] The advantages 
of this method include little or no additional costs, as CT imaging is routinely performed in AIS 
patients, as well as objectivity and reproducibility. Extensive data on the prevalence of sarcopenia 
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after stroke is available in other studies,[21] but the potential predictive value of sarcopenia in AIS 
patients treated with MT remains unknown, to the best of our knowledge. We hypothesized that 
masseter area (MA) and density (MD) measured from standard preoperative CT angiography (CTA) 
images could predict mortality in a cohort of acute stroke patients undergoing MT.  
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MATERIALS AND METHODS 
 
Patients 
Patients were treated with MT at Tampere University Hospital (TAUH) between January 2013 and 
February 2018 (n=453). We retrospectively collected the patient data and the times of death from the 
TAUH patient record database, which is linked to the National Population Register, results of the 
blood tests from the Fimlab Laboratories Ltd database and CTA images from a picture archiving and 
communication system (PACS). The initial imaging protocol of stroke patients consisted of non-
contrast-enhanced computed tomography (NCCT), CTA, and frequently also CT perfusion (CTP) 
scanning. The selection of patients as candidates for MT was conducted in a multidisciplinary team 
consisting of a stroke neurologist and a neurointerventional radiologist, and it was based on the 
absence of extensive irreversible ischemic changes and hemorrhage in NCCT, a proximal clot 
position in the internal carotid artery (ICA) or the M1 or M2 segments of the middle cerebral artery, 
and the amount of salvageable tissue in CTP imaging when available. There were no exclusion criteria 
for MT based on age, but patients with a history of moderate or severe dementia were treated 
conservatively. Patients referred to our institution from other hospitals were re-evaluated with at least 
NCCT and CTA upon arrival before proceeding to the angiographic suite. In line with the results of 
recent studies, we also treated patients within a longer timeframe, that is, patients presenting after 6 
hours from symptom onset or suffering from a wake-up stroke provided that no large infarct could be 
detected in NCCT and there was still salvageable tissue based on the CTP maps.[22,23] Thrombolysis 
in cerebral infarction scale (TICI) was used to describe the technical outcome and TICI > 2a was set 
as a threshold for good outcome. 
 
We included patients presenting with a M1- or ICA-thrombus and available digital preoperative CT 
and CTA scans (n=312, 68.8%) in the analyses. Position of the clot elsewhere in the cerebral 
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circulation resulted in exclusion from the study (n=141, 31.1%). The excluded patients did not 
significantly differ from the study subjects with respect to age, sex, or a history of diabetes, 
hypertension, coronary artery disease, or atrial fibrillation (Supplementary table 1), an ASPECT-
score of ≤7 at 0 and/or 24 hours was less common in the excluded patients. Data on dental status, 
serum creatinine, hemoglobin (Hb), or serum c-reactive protein (CRP) were not available for the 
excluded patients. Thrombus locations in the excluded cohort were as follows: M2-segment in 73, 
M3-segment in 14, basilar artery in 24, P1-segment in 8, A1-segment in 1, A2-segment 1, A3-segment 
4, and major venous thrombi in 7 cases. 9 patients with ICA or M1 thrombus were excluded due to 
the artifacts in CTA caused by metallic dental fillings. Furthermore, 15 patients were excluded due 
to major space intracranial hemorrhages detected after the procedure: 11 patients had parenchymal 
hemorrhage (PH2), one patient had parenchymal hemorrhage remote (PHr2) and three patients had 
combination of both. 
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Imaging parameters and radiological assessment 
CT scans were obtained using a 64-row multidetector CT scanner (General Electric LightSpeed VCT, 
GE Healthcare, Milwaukee, WI, USA). Brain NCCT was performed using the parameters 120 kV 
with AUTO mA and SMART mA technic, noise index 3.3, collimation 4x5 mm, 40% adaptive 
statistical iterative reconstruction (ASIR), and rotation 0.5 s. Images were obtained axially (0.625 
mm thick slices) and then contiguous axial slices were reconstructed to the thickness of 5 mm and 
coronal slices to the thickness of 2 mm. CTA was performed with helical technique using a scanning 
range from the aortic arch to the vertex of the skull. The imaging parameters were 100 kV, AUTO 
mA and SMART-mA, noise index 9, 40% ASIR, collimation 40 x 0.625 mm, rotation 0.5 s, pitch 
factor 0.984. The contrast agent (iomeprol, 350 mg I/ml, IOMERON, Bracco, Milan, Italy) was 
administered via an antecubital vein with an 18-gauge cannula using a double-piston power injector 
with a flow rate of 5 ml/s using 70 ml of contrast agent followed by a 50 ml saline flush. Automatic 
bolus triggering from the aortic arch was used.  
 
CTA images were used to measure the area (mm2) and mean radiodensity (Hounsfield Unit, HU) 
across the region of interest of the masseter muscle. The measurements were performed after sagittal 
and coronal tilt adjustment, since in our previous study head tilt was found to have a significant effect 
on MA measurements.[15] The area and mean radiodensity were calculated from the CTA sections 
according to tangents along the lower borders of the zygomatic arches in sagittal planes and along the 
lowest points of the orbitae in coronal planes. Measurements were then made 20 ± 2 mm below the 
arches by outlining the outer surface of the masseter muscles along the fasciae. We have demonstrated 
excellent inter-observer reliability of masseter area and density measurements by three independent 
observers  in our previous article.[15] In order to confirm intra-observer reliability, 30 CT scans in 
this study population were randomly selected and rated by a independent clinician in a repeated 
manner. Intraclass correlation coefficient (ICC) was determined for MA and MD measurements. The 
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presence of teeth was scored in three categories: 1) no teeth, 2) any missing teeth, and 3) no evidence 
of missing teeth. Average MA (MAavg, mean of left and right MA) and MD (MDavg, mean of left 
and right MD) were calculated. 
 
Statistical analysis 
The statistical analyses were performed with SPSS 25 for Mac OS X. Reliability of radiological 
measurements was estimated by intraclass correlation coefficient (ICC) using two-way random single 
measurement with both consistency and absolute agreement. ICC over 0.75 was classified as excellent 
reproducibility. Normality distributions of parameters were observed using histograms and Levene’s 
test. Means along with standard deviations were reported for normally distributed variables and 
medians with interquartile ranges for variables with skewed distributions. Based on normality, 
parametric or non-parametric tests were selected. The Mann-Whitney U-test was selected for non-
Gaussian variables for two independent samples and the Kruskal-Wallis test for three or more 
independent samples. The Pearson correlation coefficient analysis was used to evaluate the pairwise 
association between the risk factors or other clinical variables and muscle parameters, and statistically 
significant (p<.05) correlations were checked with the multivariable Cox regression analysis using 
backward selection algorithm. Kaplan-Meier survival analysis was used to evaluate overall survival 
using tertiles of MAavg and MDavg. When studying three-month mortality in multivariable binary 
logistic regression analysis patients were classified as being alive or dead at the three-month fixed 
time-point. Cox regression was first carried out as univariable analyses, and the proportional hazards 
assumption was tested by log-minus-log plots. This was followed by a multivariable Cox regression 
analysis that included parameters associated with mortality (p<0.1) in univariable analyses as 
covariates. Both models, Cox and logistic regression, were adjusted for age, diabetes, local 
intracranial hemorrhage, and hemoglobin (Hb) level and in addition to these, dental status, atrial 
fibrillation, and serum creatinine level, which were significant in univariable Cox regression, were 
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included in multivariable analysis. Increased CRP correlated inversely with Hb, but only the highest 
Hb value was selected for multivariable analysis in order to avoid confounding. Criteria for cerebral 
edema and local intracranial hemorrhage were determined by The Safe Implementation of 
Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Interactions between covariates and 
muscle parameters were tested by bivariate correlation. Age, sex, and dental status were examined 
and included in separate multivariable models because of their strong !" #$%&$% association with 
masseter parameters.[24] Due to the emergency nature of AIS patients undergoing MT treatment, 
weight and height data were missing in the majority of the study cohort and NIH stroke scale in 25 
patients (8.0%). We were able to calculate BSA only for 39.1% (n=122) of the patients and it was 
therefore not included in the multivariable analyses. MDavg did not correlate linearly with weight, 
height, or BSA in this subpopulation. However, in a subpopulation with the 3-month modified rankin 
scale (mRS) available (n=267, 85.6% of the population), MDavg and MAavg correlated equally with 
mRS 3-month in Pearson coefficient analysis (p=.002). The association of age with mortality was 
analyzed as a time-dependent covariate in all the Cox survival analyses. The main muscle parameters 
(MAavg and MDavg) were z-scored and reported hazard ratios (HRs) or odds ratios (ORs) correspond 
to a one standard deviation increase in the muscle parameter.  
 
Ethical considerations 
The study was conducted adhering to the ethical principles of the Declaration of Helsinki and was 
approved by the Pirkanmaa Hospital District Science Center.  
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RESULTS 
 
Patient characteristics 
The study included 312 patients (Table 1 shows the demographic data). The median age of the patients 
was 69.2 years (IQR 15.3) and 61.1% of the patients were male. Among these, 198 (63.5%) patients 
had an M1-thrombus, 74 patients (23.7%) an ICA-thrombus, and 40 patients (12.8%) had both an 
M1- and an ICA-thrombus in the preoperative CTA. TICI scale was > 2a in 283 patients (90.7%) 
indicating a good technical outcome of MT. 
 
Table 1. Characteristics of acute stroke patients subjected to mechanical thrombectomy. 
 
Risk factor n=312 
Age, median (IQR) 69.2 (15.3) 
Female (%) 115 (36.9) 
DM (%) 45 (14.4) 
HT (%) 132 (42.3) 
CAD (%) 43 (13.8) 
FA (%) 157 (50.3) 
  
M1-thrombus, n (%) 198 (63.5) 
ICA-thrombus, n (%) 74 (23.7) 
M1- and ICA-thrombus, n (%) 40 (12.8) 
  
Cerebral edema, n (%) 122 (39.1) 
Collateral Score, median (IQR) 2 (2) 
NIH Stroke Scale, median (IQR) 16 (7) 
ASPECTS 0h ! 7, n (%) 91 (29.2) 
ASPECTS 24h ! 7, n (%) 99 (31.7) 
TICI "  2b (%) 283 (90.7) 
Arrival Hb (g/l), median (IQR) 133 (22)  
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Arrival CRP(mg/l), median (IQR) 3 (7) 
Creatinine level (#mol/l), median (IQR) 77 (29) 
  
Teeth, n (%)  
   No teeth 55 (17.6) 
   Any missing teeth 184 (59.0) 
   No evidence of missing teeth 73 (23.4) 
  
MDavg (HU), (SD) 63.7 (12.4) 
MAavg (cm2), (SD) 4.3 (1.16) 
 
DM, Diabetes mellitus; HT, hypertension; CAD, Coronary artery disease; FA, atrial fibrillation; M1, 
M1 segment of the middle cerebral artery; ICA, internal carotid artery; Hb, hemoglobin; CRP, c-
reactive protein; ASPECTS, the Alberta stroke program early CT score; TICI,  Thrombolysis in 
cerebral infarction scale; MDavg, Masseter density average; MAavg, Masseter area average.
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Determinants of masseter area 
Table 2 presents the MAavg and MDavg values of the cohort. Age, dental status, and sex were 
strongly associated with MAavg and MDavg (p<.001 for all). More specifically, advanced age, 
female sex, and poor dental status were linked to decreased MAavg and MDavg.  
 
Table 2. Radiological parameters of acute stroke patients subjected to mechanical thrombectomy. 
 
  Age tertiles Teeth category  Gender  
 All (IQR) T1 T2 T3 p 1 2 3 p M F p 
             
MAavg  4.1 (1.6) 4.7 3.9 3.6 <.001a 3.3 4.1 4.8 <.001a 4.5 3.6 <.001b 
MDavg 63.8 (15.9) 70.3 63.5 59.0 <.001a 55.5 62.5 72.5 <.001a 65.5 61.0 <.001b 
 
Masseter average area (MAavg, cm2) and masseter average density (MDavg, Hounsfield Units) are 
presented as medians (interquartile range) in all patients and as medians and tertiles indicated as T1, 
T2 and T3 according to age, in different teeth categories (1=no teeth, 2=any missing teeth and 3=no 
evidence of missing teeth according to computed tomography analysis) and in male (M) and female 
(F) genders. a Statistically significant difference between the oldest and the youngest tertile and teeth 
categories (P<.05, Kruskal-Wallis test). b Statistically significant difference compared to males 
(P<.05, Mann-Whitney-U test).
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Reproducibility of the CT measurement 
Intraobserver variability of the MDavg and MAavg were excellent as tested by ICC analysis (ICC 
.839-.981, p< 0.001) (Supplementary table 2).   
 
Association of preoperative masseter area and density with mortality 
The follow-up lasted until December 31th, 2018 with the median duration being 27.4 months (IQR 
30.2, range 0-70.4 months). According to the Kaplan-Meier survival analysis, most of the deaths 
occurred within the first 3 months (n=38, 62.3% of all deaths, 3-month mortality 12.2%) and, in line 
with this, the tertiles of MDavg and MAavg were almost parallel after three months of follow-up. 
Overall, there was an inverse relationship between both MDavg and MAavg and mortality in the log-
rank test (p<.001 to p=.002) (figure 1). Long-term mortality was 19.6% (n=61) and no patients were 
lost to follow-up. The risk of death across the full range of MDavg showed an inverse linear 
relationship between standardized MDavg and mortality with a tendency for growth in the risk of 
mortality when approaching the lowest end of the MDavg range (Supplementary figure 1). 
 
Univariable and multivariable binary logistic regression analyses were used to study the association 
of risk factors with three-month survival (Tables 3). MDavg and MAavg (OR 0.61, 95% CI 0.41-
0.92, p=.018 and OR 0.57, 95% CI 0.35-0.91, p=.019; per 1-SD increase, respectively) as well as the 
Hb level (OR 0.98, 95% CI 0.96-1.00, p=.018 -.020) were independently associated with lower 
mortality. Furthermore, despite adding !"#$%&$% risk factors (age, teeth, gender) strongly associated 
with MAavg and MDavg (Table 2) in multivariable analyses, increased MDavg and MAavg persisted 
as predictors of lower mortality (MDavg OR 0.58, 95% CI 0.39-0.86, p=.007; MAavg OR 0.52, 95% 
CI 0.32- 0.85, p=.009) (Supplementary table 3). 
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In multivariable Cox regression analyses of long-term survival, increased MDavg (HR 0.69, 95% CI 
0.51-0.94, p=.017, per 1-SD increase) was independently associated with a 31% decrease in the 
probability of death, whereas MAavg was not statistically associated with long-term mortality (HR 
0.74, 95% CI 0.53-1.03, p=.075) (Supplementary table 4). When multivariable Cox regression was 
performed only on patients surviving past the first three months after the intervention (n=274), 
MDavg and MAavg no longer showed a statistically significant association with survival 
(Supplementary table 5). Patients who died within the first three months postoperatively had smaller 
MAavg (4.33 vs. 3.68 cm2, p=.001) and MDavg (64.6 vs. 57.3 HU, p=.001) compared to those alive 
after three months.  
 
Table 3. Univariable and multivariable binary logistic regression on the association with 3-month 
postoperative mortality. 
 
 Unadjusted Adjusted with MDavg Adjusted with MAavg 
Risk factor OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Age (years) 1.0 (1.0-1.1) .08* 1.00 (0.96-1.04) .92 1.00 (0.97-1.04) .97 
Gender 1.5 (0.7-2.9) .29 -  - 
DM 1.9 (0.9-4.7) .09* 1.49 (0.60-3.07) .39 1.74 (0.70-4.33) .23 
HT 1.0 (0.5-2.0) .98 - -  
CAD 2.2 (1.0-5.0) .06* 1.77 (0.70-4.46) .23 1.46 (0.58-3.64) .42 
AF 1.5 (0.7-2.9) .28 -  
- 
 
Cerebral edema 1.5 (0.7-2.9) .27 - - 
Unfavorable CS (0-1)  0.6 (0.3-1.3) .19 - - 
NIH Stroke Scale 1.0 (1.0-1.1) .21 - - 
ASPECTS 0h ! 7 1.0 (0.5-2.1) .98 -  - 
ASPECTS 24h ! 7 0.9 (0.4-1.8) .69 - - 
Arrival Hb (per unit) 1.0 (0.9-1.0) .001* 0.98 (0.96-1.00) .020* 0.98 (0.96-1.00) .018* 
Arrival CRP (per unit) 1.0 (1.0-1.0) .002* - -  
Creatinine (per unit) 1.0 (1.0-1.0) .29 - - 
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Dental status (per 
category) 0.6 (0.4-1.1) .10 - - 
MDavg 0.5 (0.4-0.8) .001* 0.61 (0.41-0.92) .018* - 
MAavg 0.5 (0.3-0.8) .002* - 0.57 (0.35-0.91) .019* 
 
Binary logistic regression analysis. A Multivariable model including parameters with P<.1 in 
univariable analysis. OR, Odds ratio; CI, Confidence interval; DM, diabetes mellitus; HT, 
hypertension; CAD, coronary artery disease; AF, atrial fibrillation; CS, collateral score; ASPECTS, 
the Alberta stroke program early CT score; Hb, hemoglobin (g/l); CRP, c-reactive protein (mg/l); 
MAavg, Masseter area average; MDavg, Masseter density average. Odds ratio (OR) estimated from 
binary logistic regression model with 3 months mortality after operation (cut-off 3 months). Odds 
ratios for MAavg and MDavg correspond to 1 standard deviation increase. * = statistical significance.  
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DISCUSSION 
 
We found that MDavg and MAavg measured from preinterventional CTA scans are independent 
predictors of three-month mortality after MT of ICA or M1-MCA occlusions in patients with AIS 
and with a good initial technical outcome. During the first three months after the intervention, 
increases of 1SD in MDavg and MAavg were associated with a 39% and a 43% decrease in the 
probability of death, respectively. However, when analyzing only patients surviving past the initial 
three months no association of MDavg and MAavg with mortality could be demonstrated. We have 
previously reported the excellent feasibility and reliability of MDavg and MAavg measurements from 
routine CT images in clinical work.[15] This study demonstrates MAavg and MDavg to be 
independent predictors of three-month mortality in AIS patients treated with MT.  
 
Wallace et al. and Hu et al. studied elderly trauma patients and found that MA correlates with 
survival.[11,16] Short- and long-term mortality were not analyzed separately in either study but 
similar to the present study, the majority of deaths occurred during the first months of follow-up. Our 
results may not be directly comparable to the findings in these earlier studies[11,16] due to differences 
in age and sex distributions, which according to our results can affect MA. In addition, the studies 
did not adjust for dental status, which has been demonstrated to be associated with MA in the present 
study and also in our previous study.[15] The association of dental status with the masseter muscle 
parameters has been proposed to be stronger than that of aging or skeletal muscle index in the 
elderly.[15,25,26] Dental status is also highly correlated with chewing ability, which, in turn, is 
associated with overall functional status.[27] In the study by Wallace et al., the patients were 
markedly older than in our study (mean age 80.0 years vs. median 69.2 years) and consequently the 
MA values were also smaller.[11] In the study by Hu et al. the proportion of males was higher than 
in our study (73.1% vs. 63.1%) and correspondingly the mean MA was larger.[16]  
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Muscle area and density are closely related, and in addition to muscle area, radiodensity has been 
demonstrated to be a marker of sarcopenia.[18] However, previous brain trauma studies[11,16] did 
not address MD which, like MA, is correlated to age, gender, and dental status.[15] Interestingly, we 
found that high mean MD value was the muscle parameter that best predicts survival. It is possible 
that fat infiltration in the masseter muscle is the first phase in the development of sarcopenia and  
signals frailty even before MA decreases, but further research is required to verify this.  
 
The strong association between MAavg and MDavg with short-term mortality in AIS patients who 
received MT differs from our previous findings in patients treated with carotid endarterectomy for 
(mostly symptomatic) ICA stenoses in that the association with improved survival in the earlier study 
was evident only in long-term.[15] This may be due to differences in patient selection in the studies, 
since AIS patients eligible for MT are treated immediately, whereas those treated with carotid 
endarterectomy are operated mainly within 2 weeks from symptom onset. Additionally, patients with 
asymptomatic carotid stenoses or suffering from severe stroke are either denied operation or operated 
on a delayed schedule. Another notable difference between our studies was the lower mean/median 
MD in carotid endarterectomy patients compared to the MT patients (53.5 ± 16.5 vs. 63.7 ± 12.4 HU) 
despite comparable age and a higher  proportion of males in the endarterectomy cohort. It is possible 
that this difference could be due to the common occurrence of stenosis also in the external carotid 
artery and the potential effect this has on the perfusion of the masseter muscles. The fact that in AIS 
patients the association of MAavg and MDavg with mortality was seen only in short-term follow-up 
can be correlated with the timing of significant changes in neuronal plasticity which might have its’ 
most significant influence on recovery during the first 3 months after stroke.[28] Our results on the 
effect of  Hb and creatinine values are in line with previous research.[29,30]  
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This was a single-center study focusing on AIS patients undergoing MT due to ICA or M1-MCA 
occlusions, which may limit the generalizability of the results. A further limitation is the retrospective 
nature of part of the data collection and measurements, which may introduce biases. Additionally, 
high quality data on the functional (as a rule the patients had pre-stroke mRS ≤2 to be eligible to MT) 
and nutritional status, or all relevant previous medications of the study subjects at the time of the MT 
was not available. However, our findings on the effect of advanced age, sex, and dental status on MA 
and MD are compatible with previous reports.[15,25,26] We consider our method of MA and MD 
measurement reliable according to excellent ICC values in the present and our previous study.[15] 
 
SUMMARY AND CONCLUSIONS 
MDavg and MAavg determined from routine pre-interventional CTA scans predict three-month 
survival in AIS patients suffering from ICA or M1-MCA occlusions treated with MT with a 1-SD 
increase in MDavg and MAavg corresponding to a 39-43 % decrease in short-term mortality.  
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FIGURE LEGENDS 
 
Figure 1. Kaplan-Meier survival plots.  Kaplan-Meier survival curve comparing patients in 
different MDavg and MAavg tertiles in acute stroke patients subjected to mechanical 
thrombectomy. Patients in the lowest tertile had a significantly worse survival according to the log-
rank test (p<.001). 
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ONLINE SUPPLEMENTS 
 
Supplementary table 1. Demographics and computed tomography angiography findings between 
excluded and included patients. 
 
Features Sample  
N=312 
Excluded  
N=141 
p-value 
Demographics 
 
  
Age median (years) 69.2 ± 16.0 69.5 ± 12.0 .815 
Male (%) 197 (63.1%) 82 (58.2.0%) .312 
Risk factors    
DM, n 45 (14.4%) 22 (15.6%) .743 
HT, n 132 (42.3%) 65 (46.1%) .451 
CAD, n 43 (13.8%) 12 (8.5%) .112 
AF, n 163 (52.2%) 65 (46.1%) .405 
Procedural variables    
 Cerebral edema, n 122 (39.1%) 57 (40.4.6%) .790 
 ASPECTS 0h ≤7, n 91 (29.2%) 19 (13.5%) .001 
 ASPECTS 24h ≤7, n 99 (31.7%) 25 (17.7%) .002 
    
 
DM, Diabetes mellitus; HT, hypertension; CAD, Coronary artery disease; AF, atrial fibrillation; 
ASPECTS, the Alberta stroke program early CT score. Statistically significant difference (P<.05, 
Kruskal-Wallis or chi-squared test).  
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Supplementary table 2. Intraclass correlation coefficient (ICC) analysis of masseter CT-
measurements. 
 
Variable ICCa 95% CI ICCb 95% CI P-value 
MAavg (cm2) .980 .959-.991 .981 .960-.991 < .001 
MDavg (HU) .841 .693-.921 .839 .692-.920 < .001 
 
a Model: Intraclass correlation coefficient (ICC) two-way random consistency. 
b Model: Intraclass correlation coefficient (ICC) two-way random absolute. 
MAavg, Masseter area average; MDavg, Masseter density average; HU; Hounsfield Units. 
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Supplementary table 3. Multivariable binary log regression analysis of 3-month mortality and effect 
of !"#$%&$% risk factors. 
 
Risk factor OR (95% CI) p-value  OR (95% CI) p-value 
Age (years) 1.01 (0.97-1.05) .741  1.00 (0.97-1.05) .703 
Sex 1.16 (0.57-2.37) .680  0.95 (0.46-1.99) .898 
Dental status (per category) 0.95 (0.49-1.83) .950  0.95 (0.49-1.83) .870 
MDavg 0.58 (0.39-0.86) .007*  - - - 
MAavg - - -  0.52 (0.32-0.85) .009* 
 
Cox regression proportional analysis. OR, Odds ratio; CI, Confidence of interval. MDavg, Masseter 
density average; MAavg, Masseter area average. Odds ratio (OR) estimated from binary logistic 
regression model with 3 month mortality after operation (cut-off 3 months). Odds ratios of MAavg 
and MDavg correspond to 1 standard deviation increase. * = statistical significance. 
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Supplementary table 4. Cox regression analysis of the effect of significant risk factors and masseter 
on long-term mortality. 
 
Risk factor HR (95% CI) p-value  HR (95% CI) p-value 
Age 1.01 (0.98-1.04) 0.592  1.01 (0.98-1.04) 0.530 
DM 1.77 (0.97-3.24) 0.063  1.81 (0.99-3.33) 0.054 
AF 1.44 (0.84-2.47) 0.187  1.55 (0.90-2.65) 0.112 
Arrival Hb 0.98 (0.97-0.99) 0.004*  0.98 (0.96-0.99) 0.001* 
Creatinine level 1.00 (1.00-1.01) 0.166  1.00 (1.00-1.01) 0.061 
Dental status 0.85 (0.53-1.36) 0.496  0.81 (0.51-1.30) 0.382 
MDavg 0.69 (0.51-0.94) 0.017*  - - - 
MAavg - - -  0.74 (0.53-1.03) 0.075 
 
Cox regression proportional hazards analysis. HR, Hazard ratio; CI, Confidence of interval; DM, 
diabetes mellitus; AF, atrial fibrillation; Hb, hemoglobin; CRP, c-reactive protein; MAavg, Masseter 
area average; MDavg, Masseter density average. Masseter area and density parameters hazard ratios 
correspond to 1 standard deviation increase. * = statistical significance. 
 
 
 27 
Supplementary table 5. Survival analysis of the patients whose survival were over 3 months after 
operation (n=274). 
 
Risk factor HR (95% CI) p-value  HR (95% CI) p-value 
Age 1.03 (0.98-1.09) 0.229  1.05 (0.99-1.10) 0.089 
DM 2.17 (0.84-5.59) 0.107  2.11 (0.82-5.45) 0.124 
AF 1.91 (0.78-4.70) 0.158  1.92 (0.78-4.70) 0.155 
Arrival Hb 0.98 (0.96-1.00) 0.078  0.98 (0.96-1.00) 0.019* 
Creatinine level 1.01 (1.00-1.02) 0.021*  1.01 (1.00-1.02) 0.026* 
Dental status 0.82 (0.37-1.80) 0.618  0.68 (0.31-1.49) 0.332 
MDavg 0.66 (0.39-1.11) 0.116  - - - 
MAavg - - -  1.02 (0.62-1.66) 0.953 
 
Cox regression proportional hazards analysis. HR, Hazard ratio; CI, Confidence interval; DM, 
diabetes mellitus; AF, atrial fibrillation; Hb, hemoglobin; CRP, c-reactive protein; MAavg, Masseter 
area average; MDavg, Masseter density average. MAavg and MDavg hazard ratios correspond to 1 
standard deviation increase. * = statistical significance. 
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Supplementary figure 1.  
The development of risk of mortality. The risk of death (hazard ratio) across the full range of average 
masseter density (HU) in acute stroke patients treated with mechanical thrombectomy. The model 
was standardized by age, diabetes mellitus, atrial fibrillation, local intracranial hemorrhage, dental 
status, Hb and serum creatinine level at time of arrival.  
 
